Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1167

    1.

    Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.

    Winnock F, Christie MR, Batstra MR, Aanstoot HJ, Weets I, Decochez K, Jopart P, Nicolaij D, Gorus FK; Belgian Diabetes Registry.

    Diabetes Care. 2001 Jul;24(7):1181-6.PMID: 11423499 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.

    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.

    J Autoimmun. 1998 Dec;11(6):643-50.PMID: 9878086 [PubMed - indexed for MEDLINE]Related articles

    3.

    IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.

    Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.

    Diabetologia. 1997 Jan;40(1):95-9.PMID: 9028724 [PubMed - indexed for MEDLINE]Related articles

    4.

    High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

    Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK.

    Diabetes Care. 2000 Jun;23(6):838-44.PMID: 10841006 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

    Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.

    Clin Exp Immunol. 1999 Apr;116(1):78-83.PMID: 10209508 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    IA-2 autoantibodies predict impending type I diabetes in siblings of patients.

    Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, Vandemeulebroucke E, Truyen I, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

    Diabetologia. 2002 Dec;45(12):1658-66. Epub 2002 Nov 12.PMID: 12488955 [PubMed - indexed for MEDLINE]Related articles

    8.

    Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.

    Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.

    Diabetologia. 2002 Jan;45(1):66-76.PMID: 11845225 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

    Decochez K, Truyen I, van der Auwera B, Weets I, Vandemeulebroucke E, de Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

    Diabetologia. 2005 Apr;48(4):687-94. Epub 2005 Mar 9.PMID: 15756536 [PubMed - indexed for MEDLINE]Related articles

    10.

    Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.

    Korhonen S, Knip MM, Kulmala P, Savola K, Akerblom HK, Knip M; Finnish Study Group for ICA Screening.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):43-8.PMID: 11921417 [PubMed - indexed for MEDLINE]Related articles

    11.

    Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry.

    Vandewalle CL, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK.

    Diabetes Care. 1997 Oct;20(10):1547-52.PMID: 9314633 [PubMed - indexed for MEDLINE]Related articles

    12.

    Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

    Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Rottiers R; Belgian Diabetes Registry.

    Diabetes Care. 2000 Aug;23(8):1072-8.PMID: 10937500 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.

    Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC.

    Diabetes. 1996 Oct;45(10):1344-9.PMID: 8826969 [PubMed - indexed for MEDLINE]Related articles

    14.

    The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.

    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.

    Horm Metab Res. 1999 Oct;31(10):564-9.PMID: 10596966 [PubMed - indexed for MEDLINE]Related articles

    15.

    HLA-DQB1 genotypes and islet cell antibodies in the identification of siblings at risk for insulin-dependent diabetes (IDDM) in Finland. Childhood Diabetes in Finland (DiMe) Study Group.

    Reijonen H, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.

    J Autoimmun. 1994 Oct;7(5):675-86.PMID: 7840859 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

    Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.

    Pediatr Diabetes. 2005 Dec;6(4):184-92.PMID: 16390386 [PubMed - indexed for MEDLINE]Related articles

    17.

    Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.

    Kimpimäki T, Kulmala P, Savola K, Vähäsalo P, Reijonen H, Ilonen J, Akerblom HK, Knip M.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1126-32.PMID: 10720050 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

    Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS.

    Diabetes. 1998 Dec;47(12):1857-66.PMID: 9836516 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.

    Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L, Yuan Y, Zhou HF, Zhou M, Hou C, Zhou WD, Peng H, Hagopian WA.

    Tissue Antigens. 2007 Nov;70(5):369-75.PMID: 17919266 [PubMed - indexed for MEDLINE]Related articles

    20.

    High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.

    Seissler J, Atik Y, Klinghammer A, Scherbaum WA.

    Horm Metab Res. 1999 Dec;31(12):657-61.PMID: 10668918 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data